About this Journal Submit a Manuscript Table of Contents
Current Gerontology and Geriatrics Research
Volume 2013 (2013), Article ID 986254, 5 pages
http://dx.doi.org/10.1155/2013/986254
Research Article

Assessment of Platelet Indices in Patients with Neurodegenerative Diseases: Mean Platelet Volume Was Increased in Patients with Parkinson’s Disease

1Medical Faculty, Istanbul Medeniyet University, Istanbul, Turkey
2Düzce University, Düzce, Turkey
3Bezmialem Vakıf University, Istanbul, Turkey

Received 18 July 2013; Revised 10 November 2013; Accepted 11 November 2013

Academic Editor: Hiroyuki Umegaki

Copyright © 2013 Abdulkadir Koçer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Borroni, N. Akkawi, G. Martini et al., “Microvascular damage and platelet abnormalities in early Alzheimer's disease,” Journal of the Neurological Sciences, vol. 203-204, pp. 189–193, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Qiu, G. Hu, M. Kivipelto et al., “Association of blood pressure and hypertension with the risk of parkinson disease: the National FINRISK study,” Hypertension, vol. 57, no. 6, pp. 1094–1100, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Pluta, M. Ulamek, and M. Jablonski, “Consideration of the ischaemic basis and treatment of Alzheimer's disease,” Folia Neuropathologica, vol. 48, no. 1, pp. 11–26, 2010.
  4. R. Pluta, M. Ułamek, and M. Jabłoński, “Alzheimer's mechanisms in ischemic brain degeneration,” The Anatomical Record, vol. 292, no. 12, pp. 1863–1881, 2009. View at Publisher · View at Google Scholar
  5. G. Tesco, Y. H. Koh, E. L. Kang et al., “Depletion of GGA3 stabilizes BACE and enhances β-secretase activity,” Neuron, vol. 54, no. 5, pp. 721–737, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Jabłoński, R. Maciejewski, S. Januszewski, M. Ułamek, and R. Pluta, “One year follow up in ischemic brain injury and the role of Alzheimer factor,” Physiological Research, vol. 60, supplement 1, pp. 113–119, 2011.
  7. D. Weisman, E. Hakimian, and G. J. Ho, “Interleukins, inflammation, and mechanisms of Alzheimer's disease,” Vitamins and Hormones, vol. 74, pp. 505–530, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Scigliano, M. Musicco, P. Soliveri, I. Piccolo, G. Ronchetti, and F. Girotti, “Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study,” Stroke, vol. 37, no. 5, pp. 1184–1188, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. I. I. Kessler, “Epidemiologic studies of Parkinson's disease: III. A community-based survey,” American Journal of Epidemiology, vol. 96, no. 4, pp. 242–254, 1972. View at Scopus
  10. R. J. Marttila and U. K. Rinne, “Arteriosclerosis, heredity, and some previous infections in the etiology of parkinson's disease. A case-control study,” Clinical Neurology and Neurosurgery, vol. 79, no. 1, pp. 46–56, 1976. View at Scopus
  11. E. Cereda, C. Pedrolli, C. Klersy, E. Cassani, R. Caccialanza, and G. Pezzoli, “Diabetes and risk of Parkinson’s disease,” Diabetes Care, vol. 34, no. 12, pp. 2614–2623, 2011. View at Publisher · View at Google Scholar
  12. G. Hu, R. Antikainen, P. Jousilahti, M. Kivipelto, and J. Tuomilehto, “Total cholesterol and the risk of Parkinson disease,” Neurology, vol. 70, no. 21, pp. 1972–1979, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. J. D. Rogers, A. Sanchez-Saffon, A. B. Frol, and R. Diaz-Arrastia, “Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease,” Archives of Neurology, vol. 60, no. 1, pp. 59–64, 2003. View at Scopus
  14. A. T. Nurden, “Platelets, inflammation and tissue regeneration,” Thrombosis and Haemostasis, vol. 105, no. 1, pp. 13–33, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. H. F. Langer and M. Gawaz, “Platelet-vessel wall interactions in atherosclerotic disease,” Thrombosis and Haemostasis, vol. 99, no. 3, pp. 480–486, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Huo and K. F. Ley, “Role of platelets in the development of atherosclerosis,” Trends in Cardiovascular Medicine, vol. 14, no. 1, pp. 18–22, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Gawaz, K. Stellos, and H. F. Langer, “Platelets modulate atherogenesis and progression of atherosclerotic plaques via interaction with progenitor and dendritic cells,” Journal of Thrombosis and Haemostasis, vol. 6, no. 2, pp. 235–242, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Muscari, S. de Pascalis, A. Cenni et al., “Determinants of Mean Platelet Volume (MPV) in an elderly population: relevance of body fat, blood glucose and ischaemic electrocardiographic changes,” Thrombosis and Haemostasis, vol. 99, no. 6, pp. 1079–1084, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. G. McKhann, D. Drachman, and M. Folstein, “Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease,” Neurology, vol. 34, no. 7, pp. 939–944, 1984. View at Scopus
  20. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association, Washington, DC, USA, 3rd edition, 1980.
  21. A. J. Hughes, S. E. Daniel, L. Kilford, and A. J. Lees, “Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases,” Journal of Neurology Neurosurgery and Psychiatry, vol. 55, no. 3, pp. 181–184, 1992. View at Scopus
  22. C. Güngen, T. Ertan, E. Eker, R. Yasar, and F. Engin, “Reliability and validity of the standardized mini mental state examination in the diagnosis of mild dementia in Turkish population,” Türk Psikiyatri Dergisi, vol. 13, no. 4, pp. 273–281, 2002.
  23. M. F. Folstein, S. E. Folstein, and P. R. McHugh, ““Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician,” Journal of Psychiatric Research, vol. 12, no. 3, pp. 189–198, 1975. View at Publisher · View at Google Scholar
  24. M. M. Hoehn and M. D. Yahr, “Parkinsonism: onset, progression and mortality,” Neurology, vol. 17, no. 5, pp. 427–442, 1967. View at Scopus
  25. A. Arıkanoğlu, M. U. Çevik, E. Uzar, A. Acar, E. Akıl, and F. Ekici, “The increase of the mean platelet volume in patients with intracerebral haemorrhage,” Turkish Journal of Neurology, vol. 18, pp. 54–56, 2012.
  26. P. Bongioanni, M. Castagna, C. Mondino, B. Boccardi, and M. Borgna, “Platelet and lymphocyte benzodiazepine binding in patients with Alzheimer's disease,” Experimental Neurology, vol. 146, no. 2, pp. 560–566, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Borroni, C. Agosti, E. Marcello, M. di Luca, and A. Padovani, “Blood cell markers in Alzheimer disease: amyloid precursor protein form ratio in platelets,” Experimental Gerontology, vol. 45, no. 1, pp. 53–56, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Cattabeni, F. Colciaghi, and M. di Luca, “Platelets provide human tissue to unravel pathogenic mechanisms of Alzheimer disease,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 28, no. 5, pp. 763–770, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Kessler, M. Shinitzky, and B. Kessler, “Number of platelet dense granules varies with age, schizophrenia and dementia,” Dementia, vol. 6, no. 6, pp. 330–333, 1995. View at Scopus
  30. N. C. Inestrosa, R. Alarcon, J. Arriagada, A. Donoso, and J. Alvarez, “Platelet of Alzheimer patients: increased counts and subnormal uptake and accumulation of [14C]5-hydroxytryptamine,” Neuroscience Letters, vol. 163, no. 1, pp. 8–10, 1993. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Yagi, N. Kohashi, R. Katori, and M. Miyazaki, “Mean platelet volume, platelet count and platelet retention rate in cerebral vascular disease and Alzheimer type dementia,” Japanese Journal of Geriatrics, vol. 21, no. 6, pp. 545–549, 1984. View at Scopus
  32. R. T. Wang, D. Jin, Y. Li, and Q. C. Liang, “Decreased mean platelet volume and platelet distribution width are associated with mild cognitive impairment and Alzheimer's disease,” Journal of Psychiatric Research, vol. 47, no. 5, pp. 644–649, 2013. View at Publisher · View at Google Scholar
  33. Y. Yesil, M. E. Kuyumcu, M. Cankurtaran et al., “Increased Mean Platelet Volume (MPV) indicating the vascular risk in Alzheimer's Disease (AD),” Archives of Gerontology and Geriatrics, vol. 55, no. 2, pp. 257–260, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Y. Gasparyan, L. Ayvazyan, D. P. Mikhailidis, and G. D. Kitas, “Mean platelet volume: a link between thrombosis and inflammation?” Current Pharmaceutical Design, vol. 17, no. 1, pp. 47–58, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Greisenegger, G. Endler, K. Hsieh, S. Tentschert, C. Mannhalter, and W. Lalouschek, “Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events?” Stroke, vol. 35, no. 7, pp. 1688–1691, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. N. M. Smith, R. Pathansali, and P. M. W. Bath, “Platelets and stroke,” Vascular Medicine, vol. 4, no. 3, pp. 165–172, 1999. View at Scopus
  37. S. Przedborski, “Inflammation and Parkinson's disease pathogenesis,” Movement Disorders, vol. 25, pp. S55–S57, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. P. S. Whitton, “Inflammation as a causative factor in the aetiology of Parkinson's disease,” British Journal of Pharmacology, vol. 150, no. 8, pp. 963–976, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Wilms, L. Zecca, P. Rosenstiel, J. Sievers, G. Deuschl, and R. Lucius, “Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications,” Current Pharmaceutical Design, vol. 13, no. 18, pp. 1925–1928, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Giles, “The platelet count and mean platelet volume,” British Journal of Haematology, vol. 48, no. 1, pp. 31–37, 1981. View at Scopus
  41. A. Muscari, S. de Pascalis, A. Cenni et al., “Determinants of Mean Platelet Volume (MPV) in an elderly population: relevance of body fat, blood glucose and ischaemic electrocardiographic changes,” Thrombosis and Haemostasis, vol. 99, no. 6, pp. 1079–1084, 2008. View at Publisher · View at Google Scholar
  42. M.-C. Morel-Kopp, L. Mclean, Q. Chen et al., “The association of depression with platelet activation: evidence for a treatment effect,” Journal of Thrombosis and Haemostasis, vol. 7, no. 4, pp. 573–581, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. V. L. Serebruany, A. H. Glassman, A. I. Malinin et al., “Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) platelet substudy,” Circulation, vol. 108, no. 8, pp. 939–944, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Flöck, A. Zobel, G. Bauriedel et al., “Antiplatelet effects of antidepressant treatment: a randomized comparison between escitalopram and nortriptyline,” Thrombosis Research, vol. 126, no. 2, pp. e83–e87, 2010. View at Publisher · View at Google Scholar · View at Scopus